InvestorsHub Logo
Followers 79
Posts 24490
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Thursday, 09/13/2018 9:52:59 AM

Thursday, September 13, 2018 9:52:59 AM

Post# of 27395
SNGX - 1.57

NIH selects Soligenix's SGX942 in the Treatment of Oral Mucositis for the Commercialization Accelerator Program


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.